Alzheimer Breakthrough Disillusionment: Confusion on FDA’s Approval of Expensive and Possibly Ineffective Drug

Share on Facebook
Share on Twitter
Share on
LinkedIn
+

Hubwonk host Joe Selvaggi talks with precision medicine expert Hannah Mamuszka and Pioneer Institute’s Bill Smith about the promises and pitfalls of the newly approved Alzheimer’s drug Aduhelm, and the challenges presented when new, expensive drugs of dubious benefit are introduced to the nation’s formulary.

Guest:

Hannah Mamuszka is Founder & CEO of ALVA10, a healthcare technology firm. Hannah has spent her 20+ year career in diagnostics – both in pharma and at diagnostics companies, in the lab and on the business side. She believes that the challenges of diagnostic technology fully impacting patient care are more commercial than technical, and conceived of ALVA10 to create a mechanism to pull technology into healthcare by aligning incentives through data. She regularly speaks on issues regarding advancement of technology in healthcare, is on the Board of Directors for two diagnostic companies and writes a column on the value of diagnostics for the Journal of Precision Medicine.

Guest Host:

Dr. William S. Smith is Pioneer’s Visiting Fellow in the Life Sciences. Dr. Smith has 25 years of experience in government and in corporate roles. His career includes senior staff positions for the Republican House leadership on Capitol Hill, the White House Office of National Drug Control Policy, and the Massachusetts Governor’s office where he served under Governors Weld and Cellucci. He spent ten years at Pfizer Inc as Vice President of Public Affairs and Policy where he was responsible for Pfizer’s corporate strategies for the U.S. policy environment. He later served as a consultant to major pharmaceutical, biotechnology and medical device companies. Dr. Smith earned his PhD in political science with distinction at The Catholic University of America.

Get new episodes of Hubwonk in your inbox!

Recent episodes:

Innovation Reduction Act: Price Controls’ Prescription for New Therapies

/
Joe Selvaggi talks with Pioneer Institute’s senior fellow Dr. Bill Smith about the changes to drug pricing laws included in the recently passed Inflation Reduction Act provisions and discuss who wins and loses as drug companies announce their response to new law.

Residents Rescuing Refugees: Welcoming Ukrainians Yearning To Breathe Free

/
Host Joe Selvaggi talks with George Mason Law Professor, author, and immigration expert Ilya Somin about the newly announced Welcome Corps program which empowers Americans to sponsor and help relocate refugees from Ukraine and other places of war and persecution.

Sinking U.S. Shipping: Ineffective Law Creates Waves for American Economy

Host Joe Selvaggi talks with Cato Institute research fellow Colin Grabow about the failure of the Jones Act, a law that sought to protect the U.S. shipbuilding and merchant marine capacity. They examine its downstream effects on inflation, supply chain fragility, and energy access that directly affect every American.

Shopping Hospital Value: Price Transparency Mandate Brings Market Forces to Medicine

Hubwonk host Joe Selvaggi talks with Pioneer Institute's senior healthcare fellow Barbara Anthony about her recently released paper, Massachusetts Hospitals: Uneven Compliance with New Federal Price Transparency Law, and how price transparency can empower consumers to shop for better value and encourage hospitals to offer more competitive costs.

Immigration Unbound: After Title 42 Comes the Deluge

Hubwonk host Joe Selvaggi talks with Todd Bensman, senior fellow at the Center For Immigration Studies, about the conditions for aspiring immigrants and border security officials at the U.S.-Mexico border and the likely effects of the expiration of Title 42, a policy that had denied asylum claims during Covid-19.

Eight Billion Minds: Unsustainable Population Bomb or Infinite Resource?

Hubwonk host Joe Selvaggi talks with Cato Scholar and author Marian Tupy about his new book, Superabundance: The Story of Population Growth, Innovation, and Human Flourishing on an Infinitely Bountiful Planet, focusing on the contrast in policy perspectives between those who see humans consumers of finite resources and those who recognize the unlimited potential of human ingenuity.

MBTA Safety Overhaul: Retooling Teams For Trustworthy Transit

/
This week on Hubwonk, host Joe Selvaggi talks with transit advocate and expert Chris Dempsey about ways in which structural change in the MBTA's safety oversight can be reformed to improve performance, engender greater trust amongst the region’s riders, and reduce transportation congestion in our growing economy.

Climate Death Toll: Will A Warming World Overwhelm Human Resiliency?

This week on Hubwonk, host Joe Selvaggi talks with climate scientist and Johns Hopkins lecturer Dr. Patrick Brown about his recent paper, Human Deaths from Hot and Cold Temperatures and Implications for Climate Change, on the factors that contribute to high climate-related mortality, and those that lead to better resiliency.

Legal Property Theft: Legal Defense Against Town Taxman Taking Neediests’ Deeds

This week on Hubwonk, host Joe Selvaggi talks with President of PioneerLegal and retired federal judge, Hon. Frank J. Bailey, about PioneelLegal’s work to advocate for the U.S. constitutional prohibition against the practice of municipalities taking an the entire value of a property to settle a relatively small tax debt, a procedure legal in Massachusetts and thirteen other states.

Right To Save: Paying Healthcare Consumers To Shop For Value

This week on Hubwonk, host Joe Selvaggi talks with healthcare policy expert Josh Archambault about the findings from his Cicero Institute report, The Right to Save: The Next Generation of Price Transparency. He outlines how to incentivize healthcare consumers to utilize price information to reduce out-of-pocket costs, and lower healthcare costs for everyone.